Lundbeck Blames EU Patent Enforcement Regimes For Generic Drug Agreements
This article was originally published in The Pink Sheet Daily
Executive Summary
The European Commission decides to fine Lundbeck and a number of generic drug manufacturers for conspiring to delay the entry of generic citalopram onto the market, but the final outcome of the case could not be decided for several years.